文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

单核细胞CD39低表达预测脓毒症患者生存不良

Low expression of CD39 on monocytes predicts poor survival in sepsis patients.
PubMed 文献 · J Intensive Care · 2025-03-10
一句话结论脓毒症患者单核细胞CD39低表达可辅助鉴别脓毒症与轻症感染及非感染性炎症,并预测28天生存不良。

该前瞻性观察性队列研究纳入206名受试者,分为健康供者、轻症感染、心脏术后非感染性炎症和脓毒症四组,采用飞行时间质谱流式(CyTOF)42标记免疫panel及流式细胞术检测单核细胞CD39(mCD39)表达。结果显示脓毒症患者mCD39表达显著低于轻症感染和术后组(p<0.05);mCD39鉴别脓毒症与轻症感染的AUC为0.877,与NII的AUC为0.935;低mCD39表达预测7天生存的AUC为0.85(p=0.037),低表达组28天生存率显著低于高表达组(56.7% vs 80.6%,p=0.016)。作者认为mCD39可能作为脓毒症诊断生物标志物及预后不良的强预测因子。

要点

  • 脓毒症患者单核细胞CD39表达显著低于轻症感染和心脏术后非感染性炎症组(p<0.05)。
  • mCD39鉴别脓毒症与轻症感染的AUC=0.877,与NII鉴别的AUC=0.935。
  • 低mCD39表达预测7天生存的AUC=0.85(p=0.037)。
  • 低mCD39表达组28天生存率56.7%,显著低于高表达组的80.6%(p=0.016)。

适用人群与场景

  • 纳入2022年4月至2023年9月浙江大学医学院附属第一医院的206名受试者,分为健康供者、轻症感染患者、心脏术后非感染性炎症患者和脓毒症患者四组。

研究设计与关键结果

  • 研究类型为前瞻性观察性队列研究,纳入206名受试者,分为健康供者、轻症感染、心脏术后非感染性炎症和脓毒症四组。
  • 脓毒症患者单核细胞CD39表达显著低于轻症感染组和心脏术后非感染性炎症组(p<0.05)。
  • mCD39鉴别脓毒症与轻症感染的AUC=0.877,鉴别脓毒症与非感染性炎症的AUC=0.935。
  • 低mCD39表达预测7天生存的AUC=0.85(p=0.037)。
  • Kaplan-Meier分析显示,低mCD39表达脓毒症患者28天生存率56.7%,显著低于高表达组的80.6%(p=0.016)。

证据类型、等级与局限

  • 证据类型:前瞻性观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,单核细胞CD39低表达可能作为脓毒症的潜在诊断生物标志物,并作为预后不良的强预测因子。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Sepsis is a critical condition associated with high morbidity and mortality, emphasizing the need for reliable biomarkers for its diagnosis and prognosis. This study uses advanced immunological techniques to evaluate monocytic CD39 (mCD39) expression as a potential marker in sepsis.

METHODS: This prospective observational cohort study included 206 participants from the First Affiliated Hospital, Zhejiang University School of Medicine between April 2022 and September 2023. Participants were categorized into four groups: healthy donors, patients with mild infections, post-cardiac surgery patients (non-infectious inflammation), and sepsis patients. Peripheral Blood Mononuclear Cells were analyzed using mass cytometry time-of-flight (CyTOF) with a 42-marker immune panel and flow cytometry targeting monocytes. Statistical analyses included ROC curves for diagnostic and prognostic performance and Kaplan-Meier survival analysis for prognostic evaluation.

RESULTS: Sepsis patients exhibited significantly lower monocytic CD39 expression than mild infection and post-surgery groups (p < 0.05). The diagnostic performance analysis revealed that mCD39 effectively distinguished sepsis from mild infection (AUC = 0.877) and non-infectious inflammation (AUC = 0.935). Prognostic analysis identified low mCD39 expression as a strong predictor of short-term survival, with a 7-day survival AUC of 0.85 (p = 0.037). Kaplan-Meier analysis showed that sepsis patients with low mCD39 expression had significantly lower 28-day survival rates (56.7% vs. 80.6%, p = 0.016).

CONCLUSIONS: Low CD39 expression on monocytes might serve as a potential diagnostic biomarker and a strong predictor of poor prognosis in sepsis patients.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Li H, Ding P, Nan Y, et al. Low expression of CD39 on monocytes predicts poor survival in sepsis patients. J Intensive Care. 2025. PMID: 40065471. doi:10.1186/s40560-025-00784-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。